Nektar Therapeutics (NKTR) Insider Transactions
1.65 ↑0.08 (5.10%)
As of May 6, 2024, 3:59pm EST.
Insider Transactions
| Transaction Date | Owner | Role | Action | Price | Total | Shares Remaining | Price Since | Source |
|---|---|---|---|---|---|---|---|---|
| 2021-05-17 | Jonathan Zalevsky | Insider | Sold 31 Shares | $18.3 | $567 | 235 | -90.98% | Link |
| 2021-05-17 | Jillian B. Thomsen | CAO | Sold 13 Shares | $18.3 | $238 | 0 | -90.98% | Link |
| 2021-05-17 | Howard W Robin | CEO | Sold 11 Shares | $18.3 | $201 | 435 | -90.98% | Link |
| 2021-05-17 | Gil M. Labrucherie | CFO | Sold 7 Shares | $18.3 | $128 | 0 | -90.98% | Link |
| 2021-05-17 | Mark Andrew Wilson | SVP | Sold 1 Shares | $18.3 | $18 | 207 | -90.98% | Link |
| 2021-05-12 | Robert Chess | Director | Sold 8 Shares | $19.34 | $155 | 288 | -91.47% | Link |
| 2021-04-14 | Robert Chess | Director | Sold 8 Shares | $18.98 | $152 | 288 | -91.31% | Link |
| 2021-02-04 | Gil M. Labrucherie | CFO | Sold 50 Shares | $19.81 | $991 | 0 | -91.67% | Link |
| 2021-02-03 | Howard W Robin | CEO | Sold 150 Shares | $19.72 | $2,958 | 608 | -91.63% | Link |
| 2021-02-03 | Mark Andrew Wilson | SVP | Sold 5 Shares | $19.45 | $97 | 0 | -91.52% | Link |
| 2021-02-02 | Gil M. Labrucherie | CFO | Sold 50 Shares | $20.17 | $1,009 | 0 | -91.82% | Link |
| 2021-01-28 | Jillian B. Thomsen | CAO | Sold 75 Shares | $18.62 | $1,397 | 0 | -91.14% | Link |
| 2020-12-15 | Curet Myriam | Director | Sold 1 Shares | $17.82 | $18 | 19 | -90.74% | Link |
| 2020-11-23 | Jonathan Zalevsky | Insider | Sold 16 Shares | $16.4 | $262 | 250 | -89.94% | Link |
| 2020-09-28 | Jeffrey Robert Ajer | Director | Sold 3 Shares | $17.25 | $52 | 25 | -90.43% | Link |
| 2020-09-25 | Robert Chess | Director | Sold 5 Shares | $17.75 | $89 | 280 | -90.70% | Link |
| 2020-09-21 | Jeffrey Robert Ajer | Director | Sold 2 Shares | $19.74 | $39 | 20 | -91.64% | Link |
| 2020-09-17 | Gil M. Labrucherie | CFO | Sold 2 Shares | $19.96 | $40 | 0 | -91.73% | Link |
| 2020-09-08 | Robert Chess | Director | Sold 8 Shares | $18.53 | $148 | 284 | -91.10% | Link |
| 2020-08-17 | Jillian B. Thomsen | CAO | Sold 1 Shares | $19.67 | $20 | 0 | -91.61% | Link |
| 2020-08-17 | Jonathan Zalevsky | Insider | Sold 26 Shares | $19.67 | $511 | 296 | -91.61% | Link |
| 2020-08-17 | Howard W Robin | CEO | Sold 11 Shares | $19.67 | $216 | 364 | -91.61% | Link |
| 2020-08-17 | Gil M. Labrucherie | CFO | Sold 6 Shares | $19.67 | $118 | 0 | -91.61% | Link |
| 2020-08-17 | Mark Andrew Wilson | SVP | Sold 1 Shares | $19.67 | $20 | 0 | -91.61% | Link |
$NKTR used to this fuckery!! Not leaving no chance !
$NKTR buying all the dips.
$NKTR we need one good push to moon this.
$NKTR I love this stonk!
$NKTR now I buy
$NKTR today will be a nice green day LFG!!!
$NKTR This may be your last opportunity to buy on the cheap??
$NKTR come on I wana jump up and down
$NKTR I gave in! Bought more 100 shares
$NKTR more calls coming in